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Abstract
Recent research indicates internet-delivered cognitive behavioural therapy
(iCBT) can reduce symptoms of post traumatic stress disorder (PTSD). This
study examined the efficacy of an internet-delivered treatment protocol that
combined iCBT and internet-delivered eye movement desensitization and
reprocessing (iEMDR), in an uncontrolled trial. Eleven of the 15 participants
completed post-treatment questionnaires. Large effect sizes were found from
pre-treatment to 3-month follow-up ( = 1.03 – 1.61) on clinician-assessed andd 
self-reported measures of PTSD, anxiety and distress, with moderate effect
sizes (  = 0.59 – 0.70) found on measures of depression and disability. Atd
post-treatment, 55% of the participants no longer met criteria for PTSD and this
was sustained at follow-up. Symptom worsening occurred in 3 of 15 (20%) of
the sample from pre- to post-treatment; however, these participants reported
overall symptom improvement by follow-up. Future research directions for
iEMDR are discussed.
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Introduction
Results of meta-analyses indicate that both trauma-focused cognitive 
behavioural therapy (TF-CBT) and eye movement desensitization 
and reprocessing (EMDR)1 are effective in reducing PTSD symp-
toms. However, barriers to accessing these treatments include stigma, 
cost, distance, low mental health literacy, and long waiting lists2,3. 
Internet-delivered psychological treatments may increase access to 
psychological therapy4. TF-CBT has been delivered via the internet 
and has shown promise in significantly reducing PTSD symptoms 
in military personnel5,6, university students7,8, and community sam-
ples in the U.S.7, Holland9, Iraq10, Australia11,12 and German-speak-
ers in Europe13. For example, in a previous study12 we evaluated an 
internet-delivered TF-CBT (iCBT) protocol with Australian adults 
with a primary diagnosis of PTSD. We found large within-group 
effect sizes (ESs) and small-to-moderate between-group ESs on 
measures of PTSD symptoms, depression, anxiety and disability, in 
a treatment group relative to a control condition. 
Time burdens on participants could hinder effective dissemination 
of internet treatments for PTSD. This study investigated the effi-
cacy of internet-delivered EMDR (iEMDR) on the basis of meta- 
analytic findings showing that outcomes from face-to-face EMDR 
are equivalent to TF-CBT with the important distinction that TF-
CBT required approximately 23 hours (SD = 11) of homework 
while EMDR required only 3 hours (SD = 4)14. iEMDR may offer 
an alternative model of remote treatment for PTSD to iCBT. The 
present study aimed to explore the acceptability and efficacy of 
iEMDR when used in conjunction with an iCBT protocol (iCBT/
iEMDR course), and evaluated using an open trial design. To increase 
generalizability of results, inclusion criteria were consistent with 
those of outpatient services. The primary hypothesis was that 
the iCBT/iEMDR course would be associated with significant 
improvements in PTSD symptoms, depression, anxiety, distress, 
and disability. 
Secondary hypotheses were that the treatment would be rated as accept-
able to participants and would not be associated with adverse events. 
Methods
The study was approved by the Macquarie University Human Research 
Ethics Committee (HREC#: 5201100382). Participants provided 
informed consent. The trial is registered with the Australian and New 
Zealand Clinical Trials registry as ACTRN12611000151932.
Participants and recruitment
Participant flow is shown in Figure 1. Participants were recruited 
from visitors to a research website that evaluates internet-elivered 
treatments (www.ecentreclinic.org). During the recruitment period, 
which ran over 2 weeks during June 2011, 32 individuals applied 
and 15 met the following inclusion criteria: (i) self-identified as 
having a principal complaint of PTSD as indicated by total scores 
above a clinical cut-off recommended to indicate probable diagno-
sis of PTSD15 (defined as > 44 on the PTSD Checklist (PCL-C)16) 
as well as a confirmed primary diagnosis of PTSD determined by 
clinician-administered interview using the PTSD Symptom Scale-
Interview (PSS–I)17; (ii) at least one month had elapsed since the 
primary trauma; (iii) no psychotherapy for PTSD during the treat-
ment period (however, supportive group and individual counselling 
that did not specifically target PTSD symptoms was permitted); (iv) 
if using psychotropic medication, no change in dosage or type of 
medication 1 month prior to or during treatment; (v) a resident of 
Australia, (vi) at least 18 years of age, (vii) had computer and internet 
access, (viii) not currently experiencing a psychotic mental illness, 
extreme current symptoms of depression (defined as a total score > 22 
or responding > 2 to Question 9 (suicidal ideation) on the Patient 
Health Questionnaire - 9 Item (PHQ-9)18, current suicidal intent and 
plan, or highly dissociative (defined as a total score above 22) on the 
Dissociative Experiences Scale – Brief Version (DES-B))19.
Measures
The primary outcome measures were severity of symptoms of 
PTSD, measured by the PSS-I and the PCL-C. The PSS-I17 is a 
17-item semi-structured clinician-administered interview based on 
the DSM-IV criteria for PTSD. The PCL-C16 is also a 17-item, self-
report scale of PTSD symptoms based on the DSM-IV criteria for 
PTSD. 
Secondary outcomes measures included the Generalized Anxiety Dis-
order 7-Item Scale (GAD-7, which measures anxiety)20, the PHQ-9 
(which measures depression)18, the Mini International Neuropsy-
chiatric Interview (MINI; which was used to determine the presence 
of a major depressive episode, panic, agoraphobia, social phobia, 
obsessive compulsive disorder, and generalized anxiety disorder)21, 
the Kessler 10 Item22 (K10; which measures general distress), and 
the Sheehan Disability Scale23 (SDS, which measures impairment 
in psychosocial functioning). Traumatic experiences were assessed 
using the Life Events Checklist (LEC)24, which provides a list of 
traumatic events and assesses the occurrence rates of common 
Criterion A1 (life-threatening) traumas according to the DSM-IV. 
Additional outcomes included completion rates (percentage of 
participants who read the six online lessons of the iCBT/iEMDR 
course within the six weeks of the course), and treatment satisfac-
tion (percentage who reported feeling satisfied with the program or 
who would recommend it to a friend).
      Changes from Version 1
We would like to thank the reviewers for their comments on this 
manuscript, which has been edited to address their feedback 
concerning following points: (i) the rationale for the development 
of iEMDR has been clarified; (ii) the participant flow process 
has been clarified; (iii) the process of anchoring the positive 
belief followed a standardized procedure, which has now been 
referenced more clearly; (iv) the section comparing findings to the 
face-to-face literature has been edited to highlight the differences 
between mixed trauma and single incident trauma samples; (v) 
symptom worsening has been clarified; (vi) references have been 
updated; (vii)  telephone support with a specialist PTSD therapist 
has been emphasized to highlight that this was not a purely 
internet-based treatment; (viii) the basis of the findings (completer 
analyses) has been clarified; and, (ix) significance indicators have 
been added to the tables.
See referee reports
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Figure 1. Participant flow chart. iEMDR: Internet-delivered eye movement desensitization and reprocessing. PHQ-9: Patient Health 
Questionnaire – 9 Item. MINI: MINI International Neuropsychiatric Interview. DES-B: Dissociative Experiences Scale – Brief Version. 
32 individuals applied for the iEMDR Course (between 14/06/2011 – 30/06/2011)
Unsuccessful Application (n=9) 
Met inclusion criteria (n=23)
Could not contact (n=1)
Unsuccessful Diagnostic Interview (n=7)
Treatment Group (n=15)
Eligible for Post-Treatment ITT Analysis (n=15)
Eligible for Follow up ITT Analysis (n=15)
Didn’t complete all lessons (n=4)
Eligible for Post-Treatment Completer Analysis
Eligible for Follow up Completer Analysis
Completed Clinician-assessed measures (n=12):
Completed Clinician-assessed measures (n=9):
Completed all lessons: n = 10
Completed all lessons: n = 8
Completed all lessons: n = 10
Completed all lessons: n = 8
Completed 2 lessons: n = 2
Completed 2 lessons: n = 1
Completed 2 lessons: n = 1
Completed 1 lesson: n = 1
Completed Self-report measures (n=11):
Completed Self-report measures (n=9):
Completed lesson 1 only (n=1)
Completed lessons 1 - 2 (n=3)
Completed Pre-Treatment Questionnaires and
Started Lesson 1 (n=15)
Did not meet diagnostic criteria (n=5)
Scored over cut-off point on DES-B (n=1)
Withdrew application (n=1)
Completed telephone interview with MINI 5.0 (n=22)
Severe depressive symptoms on PHQ-9 (n=3)
Did not complete the application (n=3)
Currently receiving CBT (n=1)
Under 18 (n=1)
Not Australian resident (n=1)
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Intervention
The iCBT/iEMDR course is a six lesson online intervention utilising 
evidence-based principles of TF-CBT25 and EMDR26. The TF-CBT 
components were similar to those used in a previous internet-based 
CBT program for PTSD12. The course comprises text-based infor-
mation and instructions and educational case stories. 
Lesson 1 of the iCBT/iEMDR course includes information about 
the causes, symptomatology and neurobiology of PTSD, how 
cognitive, behavioural, and physical symptoms maintain PTSD, 
and provides instructions for physiological de-arousal strategies. 
Lesson 2 provides the rationale for using EMDR and detailed 
instructions about a self-guided iEMDR process. Lesson 3 describes 
cognitive restructuring strategies. Lesson 4 provides more detail on 
how to use cognitive restructuring for common trauma-related cog-
nitions. Lesson 5 describes avoidance and safety behaviours and the 
principles of graded exposure. Lesson 6 describes the principles of 
relapse prevention.
iEMDR intervention: The EMDR intervention follows the 
standard EMDR treatment protocol by Shapiro26 with the following 
adaptations for self-directed use via the internet: the protocol was 
divided into a desensitisation phase (weeks 2–4) followed by a phase 
aimed at anchoring the positive belief (weeks 5–6). The desensitiza-
tion phase followed Shapiro’s protocol for reducing the Subjective 
Units of Distress (SUDS) rating to less than 2. Anchoring the positive 
belief also followed Shapiro’s protocol26 until the Validity of Cogni-
tion (VoC) rating was above 5. Participants were instructed to anchor 
the positive belief in week 5 of the course only for trauma memories 
that were no longer distressing (SUDS < 2).
iEMDR was conducted using a web-based EMDR tool (http://
www.rapidtables.com/tool/EMDR.htm). The initial session of 
EMDR was conducted with the support of the therapist (JS) who 
guided participants by telephone through the procedure while they 
accessed the web-based EMDR tool. Further therapist-guided 
EMDR was provided as requested. Participants who reported not 
having used self-guided EMDR by mid-treatment were contacted 
and offered a second guided EMDR session. Instructions for work-
ing with blockages to processing were provided in an additional 
resource one week after giving the iEMDR instructions.
Therapist
One Clinical Psychologist (JS) provided all clinical contact with 
participants, which occurred via weekly telephone calls or secure 
email. The clinician had received Level I and II training in EMDR 
by a certified EMDR instructor, and had two years experience in 
administering iCBT and in facilitating EMDR in face-to-face 
treatment. The clinician was supervised by NT.
Statistical analysis
Primary analyses were conducted using data only from question-
naire completers, defined as those who completed treatment, post-
treatment or follow-up questionnaires. A secondary set of analyses 
was performed using an intention-to-treat (ITT) model where 
missing data were addressed by carrying forward the first available 
data (i.e. baseline-observation-carried-forward model; BOCF).
Pre- to post-treatment and pre-treatment to follow-up changes 
in questionnaire scores were analysed using paired-sample 
t-tests. Effect sizes (Cohen’s d)27 were calculated based on the 
pooled standard deviation. All analyses were performed in PASW 
version 18.0 (SPSS, Inc., Chicago, IL). 
Changes in prevalence of PTSD and comorbid disorders were 
calculated based on the results of telephone administered diagnos-
tic interviews administered at pre-treatment, post-treatment and 
follow-up. 
To measure adverse events we used Tarrier’s28 definitions of treat-
ment worsening, defined as any increase in symptom scores greater 
than zero from pre- to post-treatment or follow up, and defined 
serious adverse events as self-reported hospitalizations, suicide 
attempts, or onset of substance abuse due to treatment.
Results
Baseline data
The mean age of participants was 47 years (SD = 10.4), and 10/15 
(66%) were women. Ten of 15 participants (67%) reported being 
either married or in a de facto relationship, 4/15 (27%) reported 
being separated or widowed and 1/15 (7%) reported being single 
or never married. Four of fifteen (27%) had a tertiary education, 
9/15 (60%) reported having a post-high school certificate and 2/15 
(13%) reported as having year 10 high school level education. 
One participant (7%) was in full-time employment, eight (53%) 
were employed part-time or studying and six (40%) reported being 
unemployed, retired, or disabled. Fourteen of fifteen participants 
(93%) reported having had previous mental health treatment and 
10/15 (67%) reported taking medication related to their symptoms 
of anxiety or depression. One half (5/10) of the participants who 
completed post-treatment questionnaires reported that they were 
receiving individual or group supportive counselling during the 
treatment period that was not specifically directed at the treat-
ment of PTSD symptoms (mean sessions = 3; SD = 2.1). Between 
post-treatment and follow-up, 25% (2/8) of respondents reported 
receiving ongoing supportive therapy (not specifically for PTSD) 
and 13% (1/8) commenced treatment with a psychologist spe-
cifically for PTSD (mean sessions = 4; SD = 3.5). There were 
no reported medication changes during the course. One quarter 
(2/8) of respondents reported changing their medication post-
treatment. Five participants (33%) who reported not having used 
self-guided EMDR by mid-treatment were contacted and offered 
a second EMDR session guided by the therapist via telephone. 
None elected to participate in further EMDR, citing that EMDR 
had led to an increase in re-experiencing symptoms.
Trauma history
The most common reported primary trauma was childhood sexual 
abuse (9/15; 60%), followed by childhood physical abuse (2/15; 
13%), domestic violence as an adult (2/15; 13%), witnessing 
domestic violence as a child (1/15; 7%), captivity (1/15; 7%) and 
life threatening illness (1/15; 7%). On average, the primary trauma 
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had occurred 32.8 years prior (SD = 12.5). The average age at which 
the primary trauma occurred was 13.3 years (SD = 12.9). According 
to the LEC, participants reported having experienced an average of 
9.2 types of trauma during their lifetime. The most common was 
physical assault (13/15; 87%), followed by assault with a weapon 
(12/15; 80%), and other unwanted or uncomfortable sexual experience 
(12/15; 80%). 
Attrition 
The flow is shown in Figure 1. Eleven participants (73%) completed 
all six lessons. One participant completed a single lesson and did not 
complete further assessments. Three participants completed two les-
sons, one of whom completed post-treatment and follow up assess-
ments and one who completed post-treatment assessments only. One 
participant completed six lessons, but not the post-treatment or 
follow-up assessments. Twelve participants completed clinician- 
assessed post-treatment interviews although one of these partici-
pants did not complete the self-report questionnaires. Nine participants 
completed follow-up questionnaires, including the abovementioned 
participant who had only completed two lessons. There were no pre-
treatment differences between completers and non-completers on the 
PSS-I, PCL-C or the GAD-7 at pre-treatment.
Completer analysis
Primary outcome measures. Primary outcome scores for com-
pleters improved from pre- to post-treatment as shown in Table 1. 
Paired-sample t-tests revealed significant reductions on the PSS-I 
(t
10
 = 3.66, p = 0.004) and PCL-C (t
10
 = 2.73, p = 0.021) between 
pre- and post-treatment, and between pre-treatment and follow-up 
(PSS-I: t
10
 = 4.90, p = 0.001; PCL-C: t
10
 = 4.26, p = 0.002).
Secondary outcome measures. Paired sample t-tests between pre- 
and post-treatment indicated significant reductions for completers on 
the PHQ-9 (t
9
 = 2.66, p = 0.026), GAD-7 (t
9
 = 2.31, p = 0.047), K10 
(t
9
 = 2.49, p = 0.034), but not on the SDS (t
9
 = 1.66, p = 0.131). Signifi-
cant reductions were reported between pre-treatment and follow-up on 
the PHQ-9 (t
7
 = 3.13, p = 0.017), GAD-7 (t
7 
= 4.16, p = 0.004), K10 
(t
7
 = 3.95, p = 0.006), and SDS (t
7
 = 4.15, p = 0.004).
Intention-to-treat (ITT) analysis
Primary outcome measures. A paired-sample t-test comparing 
pre- and post-treatment scores for the ITT sample revealed signifi-
cant reductions on the PSS-I (t
14
 = 3.50, p = 0.004), and this was 
maintained at follow up (t
14
 = 4.59, p < 0.0001). Scores on the PCL-C 
did not significantly improve from pre- to post-treatment (t
14
 = 2.12, 
p = 0.053). However, at follow-up, scores on the PCL-C had signifi-
cantly improved from pre-treatment (t
14
 = 17.76, p < 0.0001).
Secondary outcome measures. Paired sample t-tests for the 
ITT sample revealed significant reductions between pre- and 
post-treatment on the K10 (t
14
 = 2.20, p = 0.046) but not on the 
PHQ-9 (t
14
 = 2.12, p = 0.053), GAD-7 (t
14
 = 2.02, p = 0.063), 
or SDS (t
14
 = 1.22, p = 0.281). There was a significant differ-
ence between pre-treatment and follow-up scores on the PHQ-9 
(t
14
 = 2.46, p = 0.027), GAD-7 (t
14 
= 2.90, p = 0.012), K10 (t
14
 = 3.10, 
p = 0.008), but not on the SDS (t
14
 = 2.08, p = 0.056). 
Effect sizes 
Using the completer analysis, large effect sizes were reported on the 
PSS-I, PCL-C, GAD-7, and K10 at post-treatment and a moderate 
effect size was reported on the PHQ-9 and SDS (Table 1). Large 
effect sizes were reported on all measures between pre-treatment 
and follow-up.
Using the ITT analysis, from pre-treatment to post-treatment a large 
within-group effect size was found on the PSS-I. Moderate within-
group effects were found on the GAD-7, PHQ-9, and K10. A small 
effect size was reported on the SDS. From pre-treatment to follow-
up, large effect sizes were found on the PSS-I, PCL-C, and GAD-7, 
and moderate effect sizes for the PHQ-9, and SDS.
Clinical significance
Based on the results of the clinician and telephone-administered 
PSS-I, 6/11 (55%) participants no longer met criteria for PTSD at 
post-treatment and 5/9 (56%) no longer had PTSD at follow-up. 
Based on an ITT approach with the BOCF, 5/15 (33%) no longer 
met criteria for PTSD at post-treatment and follow-up. 
With regard to co-morbid diagnoses for completers as measured 
by clinician-administered MINI, the average number of co-morbid 
diagnoses reduced from 2.5 (SD = 2.0) at intake to 1.2 (SD = 1.0) 
at post-treatment, and further reduced to 0.6 (SD = 1.6) at follow-
up. According to an ITT analysis the average number of co-morbid 
diagnoses reduced from 2.5 (SD = 1.7) at intake to 1.4 (SD = 0.9) at 
post-treatment, and 1.1 (SD = 1.1) at follow-up. 
Adverse events
Three participants reported symptom worsening as defined by 
Tarrier28 and no participants reported serious adverse events. Of 
the participants who completed post-treatment questionnaires, 
three participants showed symptom worsening between pre- and 
post-treatment on the PCL-C, and one of these had dropped out 
of treatment after the third lesson. All three improved between 
post-treatment and follow-up such that no participants worsened 
between pre-treatment and follow-up. No participants worsened on 
the PSS-I between any time points. 
Acceptability
At post-treatment, 6/11 (55%) reported that they were very satisfied 
with the course, one participant (9%) was mostly satisfied, and 4/11 
were neutral or somewhat satisfied. None of the participants reported 
being dissatisfied with the course. Nine of 11 (82%) reported they 
would recommend this course to a friend with PTSD.




This study explored the feasibility of a combined iCBT/iEMDR 
course for treating PTSD in adults using an open-trial design. The 
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Completers 31.6 (4.7) 19.2 (9.9) 17.1 (8.5) 1.61 (0.65–2.47)* 2.32 (1.16–3.31)*
ITT 31.6 (4.7) 22.0 (9.8) 21.5 (8.6) 1.25 (0.44–2.00)* 1.45 (0.61–2.21)*
PCL-C
Completers 59.0 (11.2) 46.9 (14.9) 43.1 (13.3) 0.95 (0.08–1.76)* 1.33 (0.35–2.22)*
ITT 59.0 (11.2) 50.1 (13.3) 48.1 (11.5) 0.73 (-0.03–1.44)† 0.96 (0.18–1.69)*
GAD-7
Completers 14.1 (4.4) 9.3 (4.7) 8.0 (4.0) 1.06 (0.18–1.87)* 1.42 (0.42–2.31)*
ITT 14.1 (4.4) 11.1 (5.2) 9.9 (3.8) 0.62 (-0.13–1.34) 1.00 (0.22–1.73)*
PHQ-9
Completers 15.3 (4.2) 11.7 (6.2) 11.3 (5.5) 0.70 (-0.14–1.50)* 0.86 (-0.06–1.72)*
ITT 15.3 (4.2) 12.1 (5.3) 11.8 (4.7) 0.66 (-0.10–1.37) 0.78 (0.02–1.50)*
SDS
Completers 21.3 (5.5) 16.6 (10.8) 12.8 (8.9) 0.59 (-0.24–1.39) 1.26 (0.29–2.1)*
ITT 21.3 (5.5) 18.3 (9.9) 16.6 (8.8) 0.37 (-0.36–1.09) 0.65 (-0.1–1.36)†
K-10
Completers 32.2 (5.5) 25.8 (7.3) 24.0 (8.0) 1.03 (0.5–1.84)* 1.28 (0.30–2.16)*
ITT 32.2 (5.5) 27.7 (6.7) 26.9 (6.7) 0.73 (-0.02–1.45)* 0.85 (0.08–1.57)*
Note: Intention-to-treat (ITT) model (n=15) was employed with pre-treatment scores carried forward if post-treatment or 
follow-up data were not available. Completer data were available for 10 participants at post-treatment and 8 at follow-up. 
Abbreviations: PSS-I: PTSD Symptom Scale – Interview Version; PCL-C: PTSD Checklist – Civilian Version; GAD-7: Generalised 
Anxiety Disorder 7-Item; PHQ-9: Patient Health Questionnaire – 9 Item; K10: Kessler 10 Item; SDS: Sheehan Disability Scale. 
*p < 0.05; †p < 0.06.
results indicated significantly reduced symptoms of PTSD, depres-
sion, anxiety, distress, and disability between pre-treatment and 
three-month follow-up according to an analysis of completers. 
By post-treatment, 55% of the participants no longer met criteria 
for PTSD, and the number of comorbid diagnoses had halved. 
These reductions indicate that PTSD can be treated via the internet 
using a combination of CBT and EMDR techniques when 
telephone support from a specialist therapist is also included. With 
respect to acceptability, this protocol was moderately tolerated, 
indicating that improvements would be required for further use of 
this intervention.
Compared with ITT data from our previous trial12, the within-group 
effect size (ES) on the PCL-C was lower at post-treatment and 
follow-up. These differences may be due to changes to the proto-
col, the use of a patient sample composed primarily of childhood 
sexual abuse survivors, or due to the influence of attrition on the 
ITT analysis as a result of using a small sample. According to out-
comes from the PCL-C, these results compare favourably to other 
studies that used the same measure with mixed trauma samples in 
both face to face29,30 and online interventions11,31. However, results 
compared less favourably with face to face TF-CBT treatment of 
motor vehicle accident survivors32 indicating that outcomes could 
potentially be improved if future iCBT treatments are tailored and 
delivered to a specific trauma population.
In our trial, 3/15 (20%) reported symptom worsening according to 
the PCL-C score between pre- and post-treatment, although all three 
reported treatment gains by follow-up. Although no serious adverse 
events (e.g., hospitalizations, suicide attempts, relapse to substance 
use) occurred during the program, an increase in re-experiencing 
symptoms (such as intrusive thoughts and increased emotional/
physiological reactivity when reminded about the event) following 
iEDMR lead three participants (20%) to discontinue and five (33%) 
to cease using iEMDR. This potentially contributed to the higher 
attrition, moderate acceptability, and limited course and question-
naire completion rates, relative to our earlier study. Although this may 
have been due to exposure-based components such as iEMDR and 
in vivo exposure, it is important to note that investigations of symptom 
deterioration and adverse events from the face-to-face literature have 
failed to indicate differences between exposure- and nonexposure- 
based treatments33. Furthermore, symptom exacerbation is no higher 
than reported in waiting lists nor is it greater than the error rates of 
the instruments used to detect adverse events34,35.
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Limitations
The absence of a waitlist control condition means that the improve-
ments could have been the results of time, repeated measurement or 
other non-specific effects. The design did not allow determination 
of whether the effects were due to the iCBT or iEMDR compo-
nents. The small sample size composed of a high number of multi-
ply traumatized, childhood sexual abuse survivors may not apply to 
other PTSD populations.
Conclusions
The results of this small feasibility study indicate that the combined 
iCBT/iEMDR protocol is potentially efficacious. The magnitude of 
gains did not appear to be as large as our previous study, although 
these may have been attenuated by differences in the sample and 
iCBT protocol. These results indicate that future research of the 
relative benefits of iCBT/iEMDR is warranted.
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effectiveness of pre-existing iCBT protocols? 
The section on recruitment does not explain how 23 people qualified, but only 16 were enrolled. In
the iEMDR Intervention subsection, the authors state, “the positive belief” but do not previously
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In the discussion section, the authors state “these results compare favourably to a similar study...”
How is the study similar? Clarifying this may help contrast your findings with the following study
which used motor vehicle accident survivors. 
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